Natick, Massachusetts and Paris (ots/PRNewswire) - - New Second-Generation Training Center in Brussels to Help Medical Professionals Advance Standard of Patient Care Boston Scientific Corporation (NYSE: BSX) today announced plans for the construction of a new state-of-the art medical training facility in ...
Somerville, New Jersey (ots/PRNewswire) - ETHICON Women's Health & Urology announced today that it received CE Mark approval in Europe to market the GYNECARE TVT SECUR(i) System for female stress urinary incontinence (SUI). This new mid-urethral sling device maintains many of the key elements that made GYNECARE TVT the gold standard in SUI surgery, and optimizes ...
Natick, Massachusetts (ots/PRNewswire) - - Results to Include Nine-Month Data on TAXUS(R) Liberte(TM) Stent Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Paris Course on Revascularization (EuroPCR), which runs from May ...
Luxembourg and Mexico City (ots/PRNewswire) - - Gemplus Delivers Healthcare ID Card, Software and Services to Mexico's Seguro Popular for Patient Data Storage Gemplus International S.A. (Euronext: LU0121706294 - GEM and NASDAQ: GEMP), a world leading provider of secure card solutions announces the delivery of 3.7 million smart healthcare cards to Seguro ...
Paris (ots/PRNewswire) - Fendi and Sharon Stone have joined forces for the amfAR - American Foundation for AIDS Research. (Photo: http://www.newscom.com/cgi-bin/prnh/20060504/211357-a ) (Photo: http://www.newscom.com/cgi-bin/prnh/20060504/211357-b ) Sharon Stone, in collaboration with Fendi, has created a luxury travel set that she will auction off, with all profits to be presented to amfAR at the 'Cinema ...
Vienna, Austria (ots/PRNewswire) - Bristol-Myers Squibb Company (NYSE: BMY) today announced 96-week clinical trial results demonstrating that entecavir maintains more viral load suppression compared to lamivudine in nucleoside-naive, chronic hepatitis B e-antigen-negative (HBeAg-) patients. Data ...
Basel, Switzerland (ots/PRNewswire) - - Important Step Towards Broad Access of Herceptin for Women With Aggressive Form of Breast Cancer Roche today announced that the European Union's Committee for Human Medicinal Products (CHMP) has issued a positive recommendation for the use of Herceptin following surgery and standard chemotherapy as adjuvant treatment ...
Madrid (ots/PRNewswire) - - Revenue Amounted to 14.8 Million Euros - Marketing Expenditure Increased 52.1% to 5.1 Million Euros - The Group Invested 11.8 Million Euros in Research and Development, Up 32% Zeltia S.A. (ZEL SM; ZEL MC) today presented its financial results for the first quarter of 2006, which showed a significant increase in Research & Development (R&D) spend, to 11.8 million euros. ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced today that the Company has signed an option agreement with Cellgate Inc. of Redwood City, California. This agreement allows Isotechnika the option to obtain an exclusive license to develop and commercialize conjugates consisting of Cellgate's patented transporter technology for the topical delivery of ...
Madrid, Spain (ots/PRNewswire) - - Preliminary Tests Demonstrate That the NP031112 Molecule has a Very Innovative Therapeutic Potential - Phase I Will Consist of Two Stages: in the First One the Drug Will be Administrated in Scalating Single Doses, and in the Second One, in a Repeated Dose for Seven Days. Neuropharma, a subsidiary of the Zeltia Group ...
Natick, Massachusetts (ots/PRNewswire) - Boston Scientific Corporation (NYSE: BSX) today announced that it has completed its combination with Guidant Corporation (NYSE: GDT), creating a global leader in cardiovascular devices and one of the largest medical technology companies in the world. In a related transaction before the closing of the Boston Scientific-Guidant transaction, Guidant and Abbott closed ...
World Federation of Hemophilia
Montreal, Canada (ots/PRNewswire) - "No child born with a bleeding disorder should have to live with pain, disability, or the prospect of early death," says Mark Skinner, president of the World Federation of Hemophilia (WFH). He was speaking on the eve of World Hemophilia Day, (April 17) which has adopted the message this year of Treatment for all! "With treatment, a person with hemophilia can expect to live ...
21st Annual Meeting of the European Association of Urology (EAU), Paris, 5th - 8th April 2006 Treatment with degarelix results in fast, profound and sustained reductions in testosterone and prostate-specific antigen (PSA) levels without a testosterone surge Paris (ots) - Following the presentation today of the results of the Phase IIb programme with degarelix in prostate cancer, which are in line with previous ...
Gaithersburg, MD (ots) - Authors recommend demonstration projects to show how to best implement HPV testing as primary screen, followed by cytology An analysis of 11 European and North American studies involving more than 60'000 women, published in the April issue of the International Journal of ...
Washington D.c. (ots/PRNewswire) - PharmaMar today announces the presentation of five posters highlighting advances with three of its compounds at the 97th Annual Meeting of the American Association for Cancer Research (AACR), taking place in Washington from 1-5 April 2006. The posters include results from preclinical research on Aplidin(R), Zalypsis(R) and PM02734. PharmaMar's highlights from this year's AACR ...
Pompey, France (ots/PRNewswire) - Groupe Novasep is pleased to announce that Mr Thierry Favreau has been appointed President of its Novasep Process business. Thierry graduated from EDHEC and held several management and senor executive positions within Baxter, Becton Dickinson and Sanofi-Synthelabo. Prior to joining Groupe Novasep Thierry Favreau was CEO of Stedim Group.. "Growth will be driven by the ...
Research Triangle Park, North Carolina (ots/PRNewswire) - Quintiles Transnational Corp. today announced the appointment of Yoh Narimatsu as President and Chief Executive Officer of Quintiles Transnational Japan K.K. (Quintiles Japan) effective April 1. Narimatsu, who has more than 30 years of international business experience, will lead all operations of ...
Lund, Sweden (ots/PRNewswire) - - For Accredited International Medical Media Only AstraZeneca (LSE: AZN , NYSE: AZN) has today welcomed preliminary results from the TORCH (TOwards a Revolution in COPD Health) study1, suggesting combination therapies containing an inhaled corticosteroid (ICS) and long-acting beta 2 agonist (LABA) have the potential to show mortality benefits for COPD patients. The ...
Brussels (ots/PRNewswire) - - Stockholm Network Report Says Crisis can be Averted by Better Practice Patterns and Newer Therapies A major new report by think tank, The Stockholm Network, shows policy makers are not doing enough to tackle rising cholesterol levels. The report titled, "Cholesterol: The ...
Zurich, Suisse (ots/PRNewswire) - - Knowledge Gap of Concern to Both Physicians and Patient Groups Nine out of ten patients battling cancer in Europe have never heard of a major breakthrough in cancer treatment, known as anti-angiogenesis, according to a new survey released today. Yet, 70% of cancer ...
Ottawa, Canada (ots/PRNewswire) - The MDS Nordion Equinox, a state-of-the-art cancer therapy system, and Avanza, a patient positioning treatment table, have received CE Mark approval and are now commercially available in Europe. The Equinox is a unique external beam therapy system providing cancer care professionals with modern functionality to maximize productivity and increase flexibility ensuring patients ...
Research Triangle Park, North Carolina (ots/PRNewswire) - - Emerging U.S. company Aerovance Inc. studying COPD drug in U.K. Quintiles Transnational Corp. today announced that it has reached a significant milestone in data management -- the 200th clinical trial using Electronic Data Capture (EDC). Quintiles is using EDC in a trial being conducted in the United Kingdom for Aerovance, Inc., of Berkeley, ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. (TSX:ISA) announced today preliminary 48 week clinical data obtained from its Phase III psoriasis and extension trials for its lead immunosuppressive drug, ISA247. Patients completing the 24 week Canadian Phase III SPIRIT trial were given the opportunity to continue therapy for an additional 36 weeks or to ...
Lugano/Johannesburg (ots) - HELSINN HEALTHCARE SA, and PFIZER LABORATORIES (PTY) LTD, announce the signing of an agreement granting PFIZER in South Africa, the exclusive license and distribution rights of Aloxi® (Palonosetron hydrochloride), a therapy for the prevention of nausea and vomiting induced by ...
Toronto, Canada (ots/PRNewswire) - There are 18 million undernourished people and 7.5 million at risk of starvation and after six years of drought, crops across East Africa have failed again. National governments, local authorities and the United Nations need to respond in a timely matter as we have the means ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. will announce preliminary 48 week clinical trial data for the Company's Canadian Phase III psoriasis trial for its lead immunosuppressive drug, ISA247, on Monday, March 20th at 8:00 a.m. EST/6:00 a.m. MST. Management will provide an overview of the preliminary 48 week Phase III data following the release ...
Vienna, Austria (ots/PRNewswire) - - New Data Demonstrate "Unique", Five Year Anti-Osteoporotic Efficacy Against Both Vertebral and Non-Vertebral Fractures New five year data presented at the 6th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO 6) meeting today show that the new osteoporosis treatment Protelos(R) ...
Tokyo, Japan (ots/PRNewswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) today announced preliminary results from the latest donepezil (Product name: ARICEPT(R)) study (Study 319) on the treatment of people with vascular dementia (VaD). Preliminary efficacy results show that those who received donepezil improved on measures of cognition, ...
Lyon, France (ots/PRNewswire) - - Influenza Vaccine Worldwide Leader sanofi pasteur Contributes to Italian Influenza Pandemic Preparedness Sanofi pasteur, the vaccines business of the sanofi-aventis Group(EURONEXT: SAN; NYSE: SNY), has supplied to the Italian Ministry of Health a stock of pre-pandemic vaccine against the H5N1 avian influenza virus ...
Ingelheim, Germany (ots/PRNewswire) - - For Non-US Healthcare Professional Media Boehringer Ingelheim announced today that that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of Sifrol(R) / Mirapexin(R) ...